Table 4.
TERM | ES | NES | NOM p-val | FDR q-val | FWER p-val |
---|---|---|---|---|---|
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 0.74 | 3.51 | <0.001 | <0.001 | <0.001 |
HALLMARK_UV_RESPONSE_DN | 0.62 | 2.83 | <0.001 | <0.001 | <0.001 |
HALLMARK_MITOTIC_SPINDLE | 0.54 | 2.55 | <0.001 | <0.001 | <0.001 |
HALLMARK_G2M_CHECKPOINT | 0.52 | 2.47 | <0.001 | <0.001 | <0.001 |
HALLMARK_TGF_BETA_SIGNALING | 0.61 | 2.36 | <0.001 | <0.001 | <0.001 |
HALLMARK_HYPOXIA | 0.49 | 2.31 | <0.001 | <0.001 | <0.001 |
HALLMARK_ANGIOGENESIS | 0.62 | 2.21 | <0.001 | <0.001 | <0.001 |
HALLMARK_PROTEIN_SECRETION | 0.51 | 2.19 | <0.001 | <0.001 | <0.001 |
HALLMARK_HEDGEHOG_SIGNALING | 0.6 | 2.16 | <0.001 | <0.001 | <0.001 |
HALLMARK_INFLAMMATORY_RESPONSE | 0.45 | 2.13 | <0.001 | <0.001 | <0.001 |
HALLMARK_E2F_TARGETS | 0.44 | 2.11 | <0.001 | <0.001 | <0.001 |
HALLMARK_KRAS_SIGNALING_UP | 0.44 | 2.08 | <0.001 | <0.001 | <0.001 |
HALLMARK_TNFA_SIGNALING_VIA_NFKB | 0.42 | 2.01 | <0.001 | <0.001 | <0.001 |
HALLMARK_ANDROGEN_RESPONSE | 0.46 | 1.99 | <0.001 | <0.001 | 0.001 |
HALLMARK_IL6_JAK_STAT3_SIGNALING | 0.45 | 1.91 | <0.001 | <0.001 | 0.003 |
HALLMARK_APICAL_JUNCTION | 0.4 | 1.91 | <0.001 | <0.001 | 0.003 |
HALLMARK_GLYCOLYSIS | 0.4 | 1.9 | <0.001 | <0.001 | 0.003 |
HALLMARK_COAGULATION | 0.41 | 1.87 | <0.001 | <0.001 | 0.004 |
HALLMARK_IL2_STAT5_SIGNALING | 0.36 | 1.7 | <0.001 | 0.002 | 0.035 |
HALLMARK_COMPLEMENT | 0.35 | 1.66 | <0.001 | 0.003 | 0.054 |
ES, Enrichment score; NES, Normalized Enrichment Score; NOM p-val, Nominal p Value; FDR q-val, False Discovery Rate q Value; FWER p-val, Family-wise Error Rate p Value.